Amundi MSCI Switzerland UCITS ETF - CHF (C)

Issuer: Amundi ETF

Asset Class: Equity

TER: 25bps

Trading Currency: GBX

Pays Income: False

Listing Date: 22 Mar 2018

Ticker: CSWG

ISIN: LU1681044993

This fund offers targeted exposure to the Swiss equity market, which is renowned for its economic stability, strong currency, and roster of world-leading multinational corporations. It provides a convenient, single-product solution to invest in the largest and most liquid companies in Switzerland. The Swiss economy is characterized by its high degree of innovation, political neutrality, and robust financial sector, making it an attractive safe-haven destination for global capital, particularly during periods of market volatility. The fund is designed for investors seeking to diversify their European equity holdings with a country known for quality and resilience.

The underlying portfolio is typically concentrated in defensive sectors that are less sensitive to economic cycles, such as healthcare, consumer staples, and financial services. It is dominated by global giants like Nestlé, Novartis, and Roche, companies that derive the majority of their revenue from international markets. This provides a unique blend of single-country exposure with inherent global diversification. This composition makes the investment potentially suitable for those looking to add a layer of stability to their portfolio while gaining access to companies at the forefront of the pharmaceutical and consumer goods industries.

By tracking its benchmark index, this product offers an efficient way to capture the performance of the Swiss market. It can serve as a core component of a developed market equity allocation or as a tactical position to capitalize on the defensive characteristics of Swiss equities and the potential strength of the local currency. The investment vehicle uses a synthetic replication method to achieve its objective, aiming to deliver returns that closely mirror those of the benchmark index in a cost-effective manner.